alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
S. 2246 

One Hundred Fifteenth Congress 

of the 

United States of America 

AT THE SECOND SESSION 

Begun and held at the City of Washington on Wednesday, 

the third day of January, two thousand and eighteen 

An Act 

To designate the health care center of the Department of Veterans Affairs in 

Tallahassee, Florida, as the Sergeant Ernest I. ‘‘Boots’’ Thomas VA Clinic, and 

for other purposes. 

Be it enacted by the Senate and House of Representatives of 

the United States of America in Congress assembled, 

SECTION 1. REDESIGNATION OF A DEPARTMENT OF VETERANS 

AFFAIRS CLINIC IN FLORIDA. 

(a) DESIGNATION.—The Health Care Center of the Department 

of Veterans Affairs located at 2181 Orange Avenue in Tallahassee, 

Florida, shall after the date of the enactment of this Act be known 

and designated as the ‘‘Sergeant Ernest I. ‘Boots’ Thomas VA 

Clinic’’. 

(b) REFERENCES.—Any reference in any law, regulation, map, 

document, paper, or other record of the United States to the clinic 

referred to in paragraph (1) shall be considered to be a reference 

to the Sergeant Ernest I. ‘‘Boots’’ Thomas VA Clinic. 

Speaker of the House of Representatives. 

Vice President of the United States and

President of the Senate.
EXHIBIT 10(y)(iii)

                       EXECUTIVE COMPENSATION ARRANGEMENTS

The compensation of Victor Insetta, the Company's President and Chief Executive
Officer, and Judah Wolf, the Company's Senior Vice President, Thin Film
Products, is governed by the terms of their respective employments agreements.
Pursuant to his agreement, Mr. Insetta was paid base compensation for the fiscal
year ended June 30, 2004 of $350,000. The agreement provides for further
increases in Mr. Insetta's base salary by the Board of Directors from time to
time in its sole discretion. The agreement also provides that, as additional
annual compensation, Mr. Insetta is entitled to an amount equal to 2.5% of the
Company's net income (before such incentive compensation and before income
taxes). On February 8, 2005, the Compensation Committee of the Board of
Directors of the Company approved an increase in salary for Victor Insetta, the
Company's Chairman, President and Chief Executive Officer, from $350,000 to
$390,000 per annum, effective June 1, 2005.

Mr. Wolf's agreement provides for annual base compensation of $125,000,
increasing by 8% in each successive year of the agreement. Mr. Wolf's current
base salary under the agreement is $157,464. In addition, Mr. Wolf receives a
quarterly incentive bonus equal to 3% of the Thin Film Profit Contribution (as
defined in his agreement). Mr. Wolf's annual bonus is determined in accordance
with the Company's Officers' Bonus Plan. Any amount to which he would be
entitled under such plan shall be reduced by an amount equal to one half of one
percent of the Thin Film Profit Contribution.

The base compensation for each of Richard Monsorno, the Company's Senior Vice
President, Technology, and David Ott, the Company's Senior Vice President, New
York Operations, is determined annually by the Board of Directors. Mr.
Monsorno's and Mr. Ott's current base salaries are $214,681 and $206,000,
respectively. Each of them is also entitled to bonuses pursuant to the Company's
Officers' Bonus Plan.
Filed by Bowne Pure Compliance





Exhibit 10.2




Addendum Dated October 1, 2008 to

Master Loan and Trust Agreement




	 	 	 	 	 	 	 	 	 	 	 
	Outstanding Bond Subseries
	 
	 	 	Initial	 	 	 	Outstanding	 	 
	Subseries	 	Identification	 	 	 	Principal	 	 
	Designation	 	Number	 	CUSIP	 	Amount	 	Mode
	 
	 	 	 	 	 	 	 	 	 	 
	2005 Series A Bonds

	 	AR1
	 	644684 AH5
	 	$	12,125,000	 	 	Fixed
	 
	 	 	 	 	 	 	 	 	 	 
	2005 Series B-1 Bonds

	 	B-1R-2
	 	644684 AT9
	 	 	6,000,000	 	 	Term
	 
	 	 	 	 	 	 	 	 	 	 
	2005 Series BC-2
Bonds

	 	BC-2R-3
	 	644684 AU6
	 	 	11,360,000	 	 	Term
	 
	 	 	 	 	 	 	 	 	 	 
	2005 Series BC-3
Bonds

	 	BC-3R-1
	 	644684 AR3
	 	 	7,500,000	 	 	Term
	 
	 	 	 	 	 	 	 	 	 	 
	2005 Series BC-4
Bonds

	 	BC-4R-1
	 	644684 AS1
	 	 	12,500,000	 	 	Fixed
DISTRICT COURT OF APPEAL OF THE STATE OF FLORIDA

FOURTH DISTRICT

PAULA PENSO,

Appellant,

v.

ELIZABETH GORDON AT LAUDERHILL, LLC,

Appellee.

No. 4D22-3295 

[July 20, 2023]

Appeal from the Circuit Court for the Seventeenth Judicial Circuit, 

Broward County; Fabienne Fahnestock, Judge; L.T. Case No. CACE22-

13196 (18).

Paula Penso, Tamarac, pro se. 

George A. Minski of the Law Offices of George A. Minski, P.A., 

Hollywood, for appellee.

PER CURIAM.

Affirmed.

GROSS, GERBER and LEVINE, JJ., concur. 

* * *

Not final until disposition of timely filed motion for rehearing.
<TABLE> <S> <C>

<ARTICLE> 5
<CIK> 0000874265
<NAME> GENESIS HEALTH VENTURES, INC.
<CURRENCY> U.S. DOLLARS

<S>                             <C>
<PERIOD-TYPE>                   12-MOS
<FISCAL-YEAR-END>                          SEP-30-2000
<PERIOD-START>                             OCT-01-1999
<PERIOD-END>                               SEP-30-2000
<EXCHANGE-RATE>                                      1
<CASH>                                      22,948,000
<SECURITIES>                                27,899,000
<RECEIVABLES>                              524,634,000
<ALLOWANCES>                              (78,020,000)
<INVENTORY>                                 65,637,000
<CURRENT-ASSETS>                           617,321,000
<PP&E>                                   1,357,667,000
<DEPRECIATION>                           (250,321,000)
<TOTAL-ASSETS>                           3,127,899,000
<CURRENT-LIABILITIES>                      313,080,000
<BONDS>                                              0
<PREFERRED-MANDATORY>                      442,820,000
<PREFERRED>                                      6,000
<COMMON>                                       973,000
<OTHER-SE>                               (247,905,000)
<TOTAL-LIABILITY-AND-EQUITY>             3,127,899,000
<SALES>                                  2,433,858,000
<TOTAL-REVENUES>                         2,433,858,000
<CGS>                                      534,960,000
<TOTAL-COSTS>                            2,572,138,000
<OTHER-EXPENSES>                           155,085,000
<LOSS-PROVISION>                           490,717,000
<INTEREST-EXPENSE>                         203,570,000
<INCOME-PRETAX>                          (987,652,000)
<INCOME-TAX>                              (27,168,000)
<INCOME-CONTINUING>                      (873,043,000)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                 (10,412,000)
<NET-INCOME>                             (883,455,000)
<EPS-BASIC>                                    (18.77)
<EPS-DILUTED>                                  (18.77)



</TABLE>
/**
 * @file
 * JavaScript behavior to remove destination from contextual links.
 */

(function ($, once) {

  'use strict';

  // Bind click event to all .contextual links which are
  // dynamically inserted via Ajax.
  // @see webform_contextual_links_view_alter()
  // @see Drupal.behaviors.contextual
  $(document).on('click', '.contextual', function () {
    $(once('webform-contextual', 'a.webform-contextual', this)).each(function () {
      this.href = this.href.split('?')[0];

      // Add ?_webform_test={webform} to the current page's URL.
      // phpcs:ignore
      if (/webform\/([^/]+)\/test$/.test(this.href)) {
        this.href = window.location.pathname + '?_webform_test=' + RegExp.$1;
      }
    });
  });

})(jQuery, once);
EXHIBIT
23.1  CONSENT OF
INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM  We hereby consent to the incorporation by reference in
the Registration Statements on Forms S-3
(Nos. 333-108320, 333-112541, 333-122418, 333-134464, and 333-159365) and Forms S-8 (Nos. 33-43716, 33-71920,
333-02888, 333-69591, 333-89909, 333-87421, 333-52640, 333-43104, 333-89228,
333-89230, 333-106112, 333-106115, 333-118611, 333-134462, 333-134463,
333-147374, 333-155210, and 333-161039) of Cephalon, Inc. of our report
dated February 12, 2010, relating to the financial statements, financial
statement schedule and the effectiveness of internal control over financial
reporting, which appears in this Form 10-K.   PricewaterhouseCoopers LLP Philadelphia, PA February 12, 2010
EXHIBIT 32.1
 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 Company Report
 1.
    
    The Report fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934; and
 2.
    
    The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.
 By:
    
    /S/ W.M. RUSTY RUSHName:
    
    W.M. Rusty RushTitle:
    
    President and Chief Executive OfficerDate:
    
    May 10, 2010
```

[Congressional Bills 115th Congress]
[From the U.S. Government Publishing Office]
[S. 2030 Introduced in Senate (IS)]

<DOC>

115th CONGRESS
  1st Session
                                S. 2030

 To deem the compliance date for amended energy conservation standards 
   for ceiling fan light kits to be January 21, 2020, and for other 
                               purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            October 30, 2017

  Mr. Tillis (for himself and Mr. Heinrich) introduced the following 
bill; which was read twice and referred to the Committee on Energy and 
                           Natural Resources

_______________________________________________________________________

                                 A BILL

 
 To deem the compliance date for amended energy conservation standards 
   for ceiling fan light kits to be January 21, 2020, and for other 
                               purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Ceiling Fan Energy Conservation 
Harmonization Act''.

SEC. 2. COMPLIANCE DATE FOR AMENDED ENERGY CONSERVATION STANDARDS FOR 
              CEILING FAN LIGHT KITS.

    (a) In General.--The compliance date for the amended energy 
conservation standards established for ceiling fan light kits in the 
final rule entitled ``Energy Conservation Program: Energy Conservation 
Standards for Ceiling Fan Light Kits'' (81 Fed. Reg. 580 (January 6, 
2016)) is deemed to be January 21, 2020.
    (b) Conforming Changes.--Not later than 60 days after the date of 
enactment of this Act, the Secretary of Energy shall make such 
technical and conforming changes to any regulation, guidance document, 
or procedure as may be necessary to implement subsection (a).
                                 <all>
```
IN THE SUPREME COURT OF PENNSYLVANIA

WESTERN DISTRICT

COMMONWEALTH OF PENNSYLVANIA,

Respondent

v.

VINCENT WILLIAM PINKNEY,

Petitioner :

:

:

:

:

:

:

:

:

:

: No. 46 WAL 2017

Petition for Allowance of Appeal from

the Order of the Superior Court

ORDER

PER CURIAM

AND NOW , this 19th day of June, 2017

, the Petition for Allowance of Appeal is

DENIED

.
Exhibit 10.33



 Exhibit 10.33 
 LOCK-UP AGREEMENT 
                  ,             
  

							
	By Facsimile (                    )	  	By Facsimile ((804) 648-3404)
	Recon Technology, Ltd	  	Anderson & Strudwick, Incorporated
	Room 1401 Yong Feng Mansion	  	707 East Main Street
	123 Jiqing Road	  	20th Floor
	Nanjing, 210006	  	Richmond, Virginia 23219
	People’s Republic of China	  	Attn:	  	L. McCarthy Downs, III,
	Attn:	  	Yin Shenping,	  		  	Senior Vice President
		  	CEO	  		  	

 Re: Lock-Up Agreement 
 Dear Mr. Wang and Mr. Downs: 
 The undersigned understands that Anderson & Strudwick, Incorporated (the
“Placement Agent”), proposes to enter into a Placement Agreement with Recon Technology, Ltd (the “Company”), providing for the public offering (the “Offering”), by the Placement Agent of a minimum of
             ordinary shares and a maximum of              ordinary shares (the “Shares”). 
 In consideration of the Placement Agent’s agreement to undertake the Offering of the Shares on a “best efforts, minimum/maximum” basis,
and for other good and valuable consideration, the receipt of which is hereby acknowledged, the undersigned agrees that the undersigned will not register, offer, sell, contract to sell, grant any securities convertible into or exercisable or
exchangeable for the Shares or any warrants to purchase the Shares (including, without limitation, securities of the Company which may be deemed to be beneficially owned by the undersigned in accordance with the rules and regulations of the
Securities and Exchange Commission and securities which may be issued upon the exercise of a stock option or warrant) for a period of one hundred ninety (190) days after today. 
 The undersigned understands that the Company, the Placement Agent and the Representatives will proceed with the Offering in reliance upon this Lock-up
Agreement. 
  

			
	Very truly yours,
		
	By:	 	  

	Name:	 	  

	Its:
<PAGE>   1
                                                                    Exhibit 23.1



                         Consent of Independent Auditors


We consent to the incorporation by reference in the Registration Statements
(Forms S-8 No. 33-42933, 33-76408 and 333-05431) pertaining to the 1991 Equity
Incentive Plan, (Form S-8 No. 33-76410) pertaining to the 1993 employee Stock
Purchase Plan, and (Form S-8 No. 33-76412) pertaining to the 1992 Director Stock
Option Plan of Cambridge NeuroScience, Inc. of our report dated February 2,
2000, with respect to the consolidated financial statements of Cambridge
NeuroScience, Inc. included in the Annual Report (Form 10-K) for the year ended
December 31, 1999.



                                             /s/ Ernst & Young LLP


Boston, Massachusetts
March 13, 2000
By Notice dated October 8, 1999, and published in the                     **Federal Register**                     on October 18, 1999, (64 FR 56227), LifePoint, Inc., 10410 Trademark Street, Rancho Cucamonga, California 91730, which has been changed to 10400 Trademark Street, Rancho Cucamonga, California 91730, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed below:                

The firms plans to use gram quantities of the listed controlled substances to manufacture drug abuse test kits.

DEA has considered the factors in Title 21, United States Code, Section 823(a) and determined that the registration of LifePoint, Inc. to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated the firm on a regular basis to ensure that the company's continued registration is consistent with the public interest. These investigations have included inspection and testing of the company's physical security systems, audits of the company's records, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed above is granted.

Dated: January 27, 2000.

John H. King,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 00-3146 Filed 2-9-00; 8:45 am]

BILLING CODE 4410-09-M
[Federal Register Volume 65, Number 238 (Monday, December 11, 2000)]
[Notices]
[Pages 77354-77355]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 00-31416]


-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Docket No. RP01-138-000]


Columbia Gulf Transmission Company; Notice of Proposed Changes in 
FERC Gas Tariff

December 5, 2000.
    Take notice that on December 1, 2000, Columbia Gulf Transmission 
Company (Columbia Gulf) tendered for filings as part of its FERC Gas 
Tariff, Second Revised Volume No. 1, the following revised tariff 
sheets to become effective January 1, 2001:

Twenty-fourth Revised Sheet No. 18
Fourteenth Revised Sheet No. 18A
Twenty-fifth Revised Sheet No. 19

    Columbia Gulf states that this filing is being submitted in 
accordance with the Federal Energy Regulatory Commission's (Commission) 
order issued on September 29, 1999 in Gas Research Institute's (GRI) 
Docket No. RP99-323-000 (Order Approving Settlement) (88 FERC para. 
61,293), and in accordance with Section 33 of the General Terms and 
Conditions of its FERC Gas Tariff, Columbia is submitting revised 
tariff sheets to reflect the 2000 GRI funding mechanism.
    Columbia Gulf states that copies of its filing have been served 
upon its firm and interruptible customers and affected state 
commissions.
    Any person desiring to be heard or to protest said filing should 
file a motion to intervene or a protest with the Federal Energy 
Regulatory Commission, 888 First Street, NE., Washington, DC 20426, in 
accordance with Sections 385.214 or 385.211 of the Commission's Rules 
and Regulations. All such motions or protests must be filed in 
accordance with Section 154.210 of the Commission's Regulations. 
Protests will be considered by the Commission in determining the 
appropriate action to be taken, but will not serve to make protestants 
parties to the proceedings. Any person wishing to become a party must 
file a motion to intervene. Copies of this filing are on file with the 
Commission and are available for public

[[Page 77355]]

inspection in the Public Reference Room. This filing may be viewed on 
the web at http://www.ferc.fed.us/online/rims.htm (call 202-208-2222 
for assistance). Comments and protests may be filed electronically via 
the internet in lieu of paper. See, 18 CFR 385.2001(a)(1)(iii) and the 
instructions on the Commission's web site at http://www.ferc.fed.us/efi/doorbell.htm.

David P. Boergers,
Secretary.
[FR Doc. 00-31416 Filed 12-8-00; 8:45 am]
BILLING CODE 6717-01-M
NUMBER 13-16-00142-CV

COURT OF APPEALS

THIRTEENTH DISTRICT OF TEXAS

CORPUS CHRISTI - EDINBURG

____________________________________________________________

CARL H. SCALISE, Appellant,

v.

REBECCA SCALISE, Appellee. 

____________________________________________________________

On appeal from the County Court at Law No. 5

of Hidalgo County, Texas.

____________________________________________________________

MEMORANDUM OPINION

Before Chief Justice Valdez and Justices Rodriguez and Garza

Memorandum Opinion Per Curiam

Appellant, Carl H. Scalise, perfected an appeal from an order granting application 

for appointment of receiver entered by the County Court at Law No. 5 of Hidalgo County, 

Texas, in cause number F-2595-15-5. This cause is before the Court on appellant’s 

unopposed motion to dismiss the appeal on grounds appellant no longer wishes to pursue 

this appeal. Appellant requests that this Court dismiss the appeal.
2

The Court, having considered the documents on file and appellant’s unopposed 

motion to dismiss the appeal, is of the opinion that the motion should be granted. See

TEX. R. APP. P. 42.1(a). Appellant’s motion to dismiss is granted, and the appeal is 

hereby DISMISSED. Costs will be taxed against appellant. See TEX. R. APP. P. 42.1(d) 

("Absent agreement of the parties, the court will tax costs against the appellant."). 

Having dismissed the appeal at appellant’s request, no motion for rehearing will be 

entertained, and our mandate will issue forthwith. 

PER CURIAM

Delivered and filed this the 

21st day of April, 2016.
<PAGE>


                                                                    Exhibit 99.2
                                 [CHASE LOGO]


The Chase Manhattan Bank USA, N.A.
Wilmington, DE

March 26, 2001


Management Report on Internal Control over
Servicing of Securitized Credit Card Receivables

Management of The Chase Manhattan Bank USA, N.A. is responsible for establishing
and maintaining an effective system of internal control over servicing of
securitized credit card receivables, which is designed to provide reasonable
assurance regarding the proper servicing of securitized credit card receivables.
The system contains self-monitoring mechanisms, and actions are taken to correct
deficiencies as they are identified.

There are inherent limitations in the effectiveness of any system of internal
control, including the possibility of human error and the circumvention or
overriding of controls. Accordingly, even an effective internal control system
can provide only reasonable assurance with respect to servicing of securitized
credit card receivables. Further, because of changes in conditions, the
effectiveness of an internal control system may vary over time.

Management of The Chase Manhattan Bank USA, N.A. assessed its system of internal
control over servicing of securitized credit card receivables as of December 31,
2000 in relation to criteria for effective internal control described in
"Internal Control-Integrated Framework" issued by the Committee of Sponsoring
Organizations of the Treadway Commission. Based on this assessment, management
believes that, as of December 31, 2000, The Chase Manhattan Bank USA, N.A.
maintained an effective system of internal control over servicing of securitized
credit card receivables.

/s/ Michael Barrett
------------------------------
Michael Barrett
President
Chase Manhattan Bank USA, N.A.


/s/ Keith Schuck
------------------------------
Keith Schuck
Vice President/Chief Financial Officer
Chase Manhattan Bank USA, N.A.
#### The State of Ohio, Appellee, *v.*DelBene, Appellant.

(No. 28752

Decided October 1, 1941.)

*Mr. William A. Ambrose,*prosecuting attorney, and *Mr. Harold H. Hull,*for appellee.

*Mr. W. P. Barmtm*and *Mr. P. J. Melillo,*for appellant.

It is ordered and adjudged that this appeal as of right he, and the same hereby is, dismissed for the reason that no debatable constitutional question is involved.

*Appeal dismissed.*

Weygandt, C. J., Turner,, Williams, Matthias, Zimmerman and Bettman, JJ., concur.